Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sixty Degree Capital is a global investment firm founded in 2017 and based in Toronto, Canada. The organization specializes in investing in high-potential companies within the healthcare and technology sectors. It manages over $620 million in assets under management (AUM) and has achieved more than 12 successful exits.
Sixty Degree Capital invests in companies across various stages, from pre-seed to growth stages. The firm focuses on sectors including technology (AI, cybersecurity, digital infrastructure, SaaS) and healthcare (drug development, diagnostics, digital health, medical devices).
Notable portfolio companies include: - **TripActions**: A business travel and expense management platform that utilizes AI to optimize corporate travel spend. - **Paperspace**: A cloud infrastructure provider focused on high-performance computing and AI/ML workloads. - **Arcellx**: A clinical-stage biotech company developing engineered immune cell therapies for cancer treatment. - **CinCor Pharma**: A clinical-stage biotech company focused on treatments for cardiorenal disease, acquired by AstraZeneca in 2023. - **Monte Rosa Therapeutics**: A biotech company developing molecular glue degraders for oncology and immunology conditions. - **Kraken**: A digital asset platform known for its security and wide-ranging support for cryptocurrencies. - **Everside Health**: An oncology-focused pharmaceutical company developing novel drugs for cancer treatment. - **Veem**: A fintech platform simplifying cross-border payments for small and medium businesses.
To approach Sixty Degree Capital, founders should visit their website at sixtydegreecapital.com to submit their pitch. The firm values a thesis-driven approach and looks for high-potential companies that align with their investment focus.
Sixty Degree Capital has been actively deploying its Fund III, which has a size of $250 million. Recent investments include notable companies such as Cato Networks, Docker, and Navan. The firm has achieved over 12 successful exits, including the acquisition of CinCor Pharma by AstraZeneca for $1.8 billion in 2023.
Sixty Degree Capital invests in companies across various stages, including Pre Seed, Seed, Series A, Series A Plus, Series B, Growth Equity, and Pre IPO.
Founders can pitch Sixty Degree Capital through their website at sixtydegreecapital.com.
The firm focuses on sectors such as AI, cybersecurity, digital infrastructure, SaaS, biotech, and healthcare.
Sixty Degree Capital typically invests between $1 million and $10 million in its portfolio companies.
Sixty Degree Capital invests globally, with a strong presence in North America, particularly the United States and Canada.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.